BackSoaring Eagle Acquisition Overview

Soaring Eagle Acquisition Other Current Liabilities

Track Soaring Eagle Acquisition's other current liabilities ($48M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$48.38M
18.67% YoYΔ $-11.10M vs prior year quarter

Peer average

Loading

Soaring Eagle Acquisition Other Current Liabilities History

Loading

Soaring Eagle Acquisition vs. peers: Other Current Liabilities Comparison

Loading

Soaring Eagle Acquisition Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Soaring Eagle Acquisition (SRNG) FAQ

Soaring Eagle Acquisition (SRNG) currently reports a other current liabilities of $48M as of March 2026. That compares with $59M in the prior-year period — down 18.7% year over year. Use the charts on this page to explore Soaring Eagle Acquisition's other current liabilities history and peer comparisons.

Soaring Eagle Acquisition's other current liabilities decreased from $59M to $48M — a 18.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Soaring Eagle Acquisition reported $48M in other current liabilities as of March 2026. That compares with $59M in the prior-year period — down 18.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $48M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Soaring Eagle Acquisition, and consider following SRNG for alerts when major investors trade the stock.

Soaring Eagle Acquisition is classified in the Healthcare sector. On other current liabilities, it currently shows $48M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SRNG with unrelated industries.